Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kadmon

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
The Prostate|January 1, 1981
Effect of surgery and adjuvant chemotherapy on the R3327 MAT-Ly Lu tumorD Kadmon, W D Heston, W R Fair
The Journal of Urology|June 1, 1982
Treatment of a metastatic prostate derived tumor with surgery and chemotherapyD Kadmon, W D Heston, W R Fair
The Journal of Urology|May 1, 1989
The role of transrectal ultrasonography in the diagnosis and management of prostatic and seminal vesicle cystsR Shabsigh, S Lerner, I J Fishman, et al.
The Prostate|January 1, 1985
Effect of estrogen and androgen administration on alpha-difluoromethylornithine-enhanced putrescine uptake by the rat prostateD Kadmon, C Mahle, W D Heston, et al.
The Journal of Urology|April 1, 1994
Transitional cell carcinoma in a tuberculous kidney: case report and review of the literatureD Feeney, E T Quesada, D M Sirbasku, et al.
The Journal of Urology|November 1, 1982
Immunotherapy of superficial bladder cancerA Shapiro, D Kadmon, W J Catalona, et al.
The Prostate|January 1, 1982
Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of the ODC inhibitor alpha-difluoromethylornithineW D Heston, D Kadmon, D W Lazan, et al.
Cancer Research|April 1, 1982
Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propaneD W Lazan, W D Heston, D Kadmon, et al.
Urology|November 1, 1996
Intracranial metastases as the first manifestation of prostate cancerM A Sutton, H L Watkins, L K Green, et al.
The Journal of Urology|August 1, 1991
Elevated plasma chromogranin-A concentrations in prostatic carcinomaD Kadmon, T C Thompson, G R Lynch, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
The Prostate|January 1, 1981
Effect of surgery and adjuvant chemotherapy on the R3327 MAT-Ly Lu tumorD Kadmon, W D Heston, W R Fair
The Journal of Urology|June 1, 1982
Treatment of a metastatic prostate derived tumor with surgery and chemotherapyD Kadmon, W D Heston, W R Fair
The Journal of Urology|May 1, 1989
The role of transrectal ultrasonography in the diagnosis and management of prostatic and seminal vesicle cystsR Shabsigh, S Lerner, I J Fishman, et al.
The Prostate|January 1, 1985
Effect of estrogen and androgen administration on alpha-difluoromethylornithine-enhanced putrescine uptake by the rat prostateD Kadmon, C Mahle, W D Heston, et al.
The Journal of Urology|April 1, 1994
Transitional cell carcinoma in a tuberculous kidney: case report and review of the literatureD Feeney, E T Quesada, D M Sirbasku, et al.
The Journal of Urology|November 1, 1982
Immunotherapy of superficial bladder cancerA Shapiro, D Kadmon, W J Catalona, et al.
The Prostate|January 1, 1982
Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of the ODC inhibitor alpha-difluoromethylornithineW D Heston, D Kadmon, D W Lazan, et al.
Cancer Research|April 1, 1982
Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propaneD W Lazan, W D Heston, D Kadmon, et al.
Urology|November 1, 1996
Intracranial metastases as the first manifestation of prostate cancerM A Sutton, H L Watkins, L K Green, et al.
The Journal of Urology|August 1, 1991
Elevated plasma chromogranin-A concentrations in prostatic carcinomaD Kadmon, T C Thompson, G R Lynch, et al.
Pageof 7